Imunon Inc.

NASDAQ: CLSN · Real-Time Price · USD
1.95
-0.01 (-0.51%)
At close: Sep 21, 2022, 6:00 AM

Imunon Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2021
Revenue
n/a 500K
Cost of Revenue
n/a n/a
Gross Profit
n/a 500K
Operating Income
-19.13B -21.01M
Interest Income
n/a 18.14K
Pretax Income
-18.62B -22.15M
Net Income
-18.62B -20.77M
Selling & General & Admin
7.49B 10.89M
Research & Development
11.64B 10.62M
Other Expenses
n/a n/a
Operating Expenses
19.13B 21.51M
Interest Expense
n/a 569.88K
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
n/a 21.51M
Income Tax Expense
n/a -1.38M
Shares Outstanding (Basic)
11.51M 5.42M
Shares Outstanding (Diluted)
11.51M 5.42M
EPS (Basic)
-1.62 -3.83
EPS (Diluted)
-1.62 -3.83
EBITDA
-19.13B -20.88M
EBIT
n/a -22.16M
Depreciation & Amortization
n/a 702.92K